Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12614000396628
Ethics application status
Approved
Date submitted
1/04/2014
Date registered
10/04/2014
Date last updated
4/02/2016
Type of registration
Prospectively registered
Titles & IDs
Public title
Is two days of intermittent fasting per week a feasible weight loss approach in obese male war veterans? A pilot study.
Query!
Scientific title
For obese male war veterans aged between 55-75 years, will two days of intermittent fasting per week when compared with a standard 500kcal reduced diet promote more weight loss.
Query!
Secondary ID [1]
284376
0
Nil known
Query!
Universal Trial Number (UTN)
U1111-1155-1826
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Obesity
291543
0
Query!
Condition category
Condition code
Diet and Nutrition
291922
291922
0
0
Query!
Obesity
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Intermittent Fasting Group
Participants will be asked to follow a diet containing only 500kcal for two non-consecutive days per week and eat normally (unrestricted but encouraged to follow healthy eating guidelines) on the other five days for 6 months. Participants will be taught how to count calories and recieve dietary advice regarding healthy eating and food portions (as per Australian Guide to Healthy Guidelines). A calorie counting book will be provided. They will receive regular dietetic review and monitoring during the first 3 months (baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks) and minimal contact during the remaining 3 months. The initial session with the dietitian at baseline will be 45 minutes in duration and all subsequent reviews will be 30 minutes in duration. Participants will have biochemical markers (fasting lipids and fasting glucose), biological impedence (to estimate percentage body fat), waist circumference and blood pressure taken at baseline, 3 months and 6 months. They will also complete a food frequency questionnaire and a validated quality of life questionnaire (AQoL 8D scale) at these times. Participants will have weight monitored and will be questioned about their compliance with the diet at all reviews (baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks and 6 months). In order to promote compliance, participants will be provided with sample recipes and will be able to contact the study dietitian during business hours for further clarification or dietary advice.
Query!
Intervention code [1]
289105
0
Treatment: Other
Query!
Intervention code [2]
289159
0
Lifestyle
Query!
Comparator / control treatment
Standard Treatment (Standard Calorie Restricted Group)
Participants will be asked to follow a diet approximately 500kcal less than energy requirements every day for 6 months. Participants will recieve dietary advice regarding healthy eating and food portions (as per Australian Guide to Healthy Guidelines) to achieve this. They will receive regular dietetic review and monitoring during the first 3 months (baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks) and minimal contact during the remaining 3 months. Participants will have biochemical markers (fasting lipids and fasting glucose), biological impedence (to estimate percentage body fat), waist circumference and blood pressure taken at baseline, 3 months and 6 months. They will also complete a food frequency questionnaire and a validated quality of life questionnaire (AQoL 8D scale) at these times. Participants will have weight monitored and will be questioned about their compliance with the diet at all reviews (baseline, 2 weeks, 4 weeks, 8 weeks, 12 weeks and 6 months). In order to promote compliance, participants will be provided with sample recipes and will be able to contact the study dietitian during business hours for further clarification or dietary advice.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
291828
0
Percentage weight loss. Weight will be measured on the same scales and scales will be calibrated prior to the trial commencing.
Query!
Assessment method [1]
291828
0
Query!
Timepoint [1]
291828
0
Baseline and at 2 weeks, 4 weeks, 8 weeks, 12 weeks and 6 months after intervention commencement
Query!
Secondary outcome [1]
307628
0
Total cholesterol (fasting) as assessed by testing collected blood
Query!
Assessment method [1]
307628
0
Query!
Timepoint [1]
307628
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Secondary outcome [2]
307629
0
LDL cholesterol (fasting) as assessed by testing collected blood
Query!
Assessment method [2]
307629
0
Query!
Timepoint [2]
307629
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Secondary outcome [3]
307630
0
HDL cholesterol (fasting) as assessed by testing collected blood
Query!
Assessment method [3]
307630
0
Query!
Timepoint [3]
307630
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Secondary outcome [4]
307631
0
Tryglycerides (fasting) as assessed by testing collected blood
Query!
Assessment method [4]
307631
0
Query!
Timepoint [4]
307631
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Secondary outcome [5]
307632
0
Fasting glucose as assessed by testing collected blood
Query!
Assessment method [5]
307632
0
Query!
Timepoint [5]
307632
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Secondary outcome [6]
307633
0
Waist circumference (cm) as assessed by using a standard measuring tape
Query!
Assessment method [6]
307633
0
Query!
Timepoint [6]
307633
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Secondary outcome [7]
307634
0
Percentage body fat as assessed using biological impedence machine
Query!
Assessment method [7]
307634
0
Query!
Timepoint [7]
307634
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Secondary outcome [8]
307635
0
Quality of life as assessed by using an AQoL 8D scale
Query!
Assessment method [8]
307635
0
Query!
Timepoint [8]
307635
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Secondary outcome [9]
307636
0
Food intake as assessed by completion of food frequency questionnaire (DQES)
Query!
Assessment method [9]
307636
0
Query!
Timepoint [9]
307636
0
Baseline and at 3 months and 6 months after intervention commencement
Query!
Eligibility
Key inclusion criteria
Male war veteran aged 55-75 years old
Have a BMI greater than or equal to 30kg/m2
Have a stable body weight (+/- 5% body weight change in the last 3 months)
Have own local doctor who is aware of the health issues of the participant
Query!
Minimum age
55
Years
Query!
Query!
Maximum age
75
Years
Query!
Query!
Sex
Males
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Have a medical contraindication (e.g. active cancer, unstable diabetes, insulin dependent diabetes, end stage renal failure)
Have a high alcohol intake (greater than 28 standard drinks per week)
Are taking antpsychotic medication associated with weight gain (Mirtazapine, Olanzapine, Clozapine)
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation Concealment
A simple randomisation protocol will be used to allocate participants to one of two dietary
intervention groups; the Intermittent Fasting Group (IFG) or the Standard Calorie Restricted
Group (SCRG). Numbered tokens representing
the total number of participants (i.e. numbered from 1-30) will be placed in an envelope. Once a participant has been recruited, an offsite administrator will then be asked to pull out a token for the participant and inform the principal investigator. The offsite administrator will not be told what the numbers represent and is not involved in any other aspect of the trial. Participants who are drawn an odd
number will be allocated to Intermittent Fasting Group (IFG) and participants who are
drawn an even number will be allocated to the Standard Calorie Restricted Group (SCRG).
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Numbered tokens representing
the total number of participants (i.e. numbered from 1-30) will be placed in an envelope. Once a participant has been recruited, an offsite administrator will then be asked to pull out a token for the participant and inform the principal investigator. The offsite administrator will not be told what the numbers represent and is not involved in any other aspect of the trial. Participants who are drawn an odd
number will be allocated to one group and those drawn an even number will be allocated to the other group.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
This is a pilot study so sample size calculations were not performed.
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
22/04/2014
Query!
Actual
20/05/2014
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
7/04/2015
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
30
Query!
Accrual to date
Query!
Final
25
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
2288
0
Austin Health - Heidelberg Repatriation Hospital - Heidelberg West
Query!
Recruitment postcode(s) [1]
7967
0
3081 - Heidelberg West
Query!
Funding & Sponsors
Funding source category [1]
289016
0
Charities/Societies/Foundations
Query!
Name [1]
289016
0
Austin Medical Research Foundation
Query!
Address [1]
289016
0
Austin Hospital
145 Studley Road
PO Box 5555
Heidelberg
Victoria
Australia 3084
Query!
Country [1]
289016
0
Australia
Query!
Funding source category [2]
289017
0
Charities/Societies/Foundations
Query!
Name [2]
289017
0
Dietitians Association of Australia
Query!
Address [2]
289017
0
1/8 Phipps Close
DEAKIN
ACT 2600
Query!
Country [2]
289017
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Lauren Le Fevre
Query!
Address
Heidelberg Reaptriation Hospital
300 Waterdale Road
PO Box 5444
Heidelberg West
Victoria 3081
Query!
Country
Australia
Query!
Secondary sponsor category [1]
287693
0
Individual
Query!
Name [1]
287693
0
Marguerite Conley
Query!
Address [1]
287693
0
Heidelberg Repatriation Hospital
300 Waterdale Road
PO Box 5444
Heidelberg West
Victoria 3081
Query!
Country [1]
287693
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
290823
0
Austin Health Human Research Ethics Committee
Query!
Ethics committee address [1]
290823
0
Austin Hospital 145 Studley Road PO Box 5555 Heidelberg Victoria Australia 3084
Query!
Ethics committee country [1]
290823
0
Australia
Query!
Date submitted for ethics approval [1]
290823
0
24/01/2014
Query!
Approval date [1]
290823
0
02/04/2014
Query!
Ethics approval number [1]
290823
0
HREC/14/Austin/33
Query!
Summary
Brief summary
This pilot study aims to determine whether the intermittent fasting approach leads to greater weight loss and greater improvements in blood sugar, cholesterol and blood pressure than a standard low energy diet in obese male war veterans. Our primary objective is to determine whether obese, male war veterans who undertake intermittent fasting (5:2 method) achieve at least 5% weight loss in six months.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
47434
0
Mrs Lauren Le Fevre
Query!
Address
47434
0
Heidelberg Repatriation Hospital
300 Waterdale Road
PO Box 5444
Heidelberg West
Victoria 3081
Query!
Country
47434
0
Australia
Query!
Phone
47434
0
+61394965011
Query!
Fax
47434
0
Query!
Email
47434
0
[email protected]
Query!
Contact person for public queries
Name
47435
0
Marguerite Conley
Query!
Address
47435
0
Heidelberg Repatriation Hospital
300 Waterdale Road
PO Box 5444
Heidelberg West
Victoria 3081
Query!
Country
47435
0
Australia
Query!
Phone
47435
0
+61394965011
Query!
Fax
47435
0
Query!
Email
47435
0
[email protected]
Query!
Contact person for scientific queries
Name
47436
0
Marguerite Conley
Query!
Address
47436
0
Heidelberg Repatriation Hospital
300 Waterdale Road
PO Box 5444
Heidelberg West
Victoria 3081
Query!
Country
47436
0
Australia
Query!
Phone
47436
0
+61394965011
Query!
Fax
47436
0
Query!
Email
47436
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Dimensions AI
Is two days of intermittent energy restriction per week a feasible weight loss approach in obese males? A randomised pilot study
2017
https://doi.org/10.1111/1747-0080.12372
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF